AMGN vs IPEXR
Amgen Inc (AMGN) versus Inflection Point Acquisition Corp. V (IPEXR) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Inflection Point Acquisition Corp. V (IPEXR) common stock listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
IPEXR does not have a complete income-statement cache yet.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. IPEXR currently screens at market cap $0.
Not investment advice. Open the AMGN and IPEXR stock pages for the full models.
Not investment advice.